EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluating Cost‐Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus

Ravi Vissapragada, Norma B Bulamu, Roger Yazbeck iD, Tomonori Aoki, Tim Bright, David I Watson, Jonathan Karnon

Journal of Gastroenterology and Hepatology · 2026-03 · 41 (3) · 992-1000

DOI: 10.1111/jgh.70238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 19.01.2026. Verfasst von Ravi Vissapragada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Surgery, College of Medicine and Public Health, Flinders University, Adelaide, Australia. Hauptthemen laut MEDLINE: Barrett Esophagus, Cost-Benefit Analysis, Cost-Effectiveness Analysis, Esophageal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hospital Research Foundation, APAGE/JGH Foundation Clinician-Scientist Training Fellowship, Cancer Council South Australia Beat Cancer Early Career Research Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Barrett's esophagus is the known precursor to esophageal adenocarcinoma (EAC), a cancer with poor prognosis. While endoscopic surveillance detects early dysplasia and prevents progression, most Barrett's esophagus patients do not progress to EAC, leading to invasive and costly surveillance. This study aimed to identify cost‐effective endoscopic surveillance strategies by risk stratifying patients based on Barrett's esophagus segment length and sex.

Methods

A Markov cohort model was developed to simulate the natural history of Barrett's esophagus to EAC. The model assessed 85 surveillance strategies and varied endoscopy intervals from 2 to 10 years for nondysplastic Barrett's esophagus and 6–12 months for dysplasia. Risk stratification was based on segment length (≤ 2 and ≤ 3 cm) and sex. Costs, utilities and transition probabilities were derived from published literature and clinical databases. Deterministic and probabilistic sensitivity analyses were performed, and cost‐effectiveness was evaluated from a third‐party payer perspective using a threshold of AU$50 000/QALY (2023 US dollars 35 945/QALY).

Results

The most cost‐effective strategy was biennial surveillance for long‐segment BE (> 2 cm) and 12‐month surveillance for LGD, excluding surveillance in low‐risk patients (ICER US$23 737/QALY). Risk‐based surveillance consistently outperformed nonstratified strategies. Sensitivity analyses confirmed the robustness of the model, with key drivers being transition rates and endoscopy costs.

Conclusion

We identified cost‐effective risk‐stratified endoscopic surveillance strategies for Barrett's esophagus, particularly when excluding low‐risk patients. Tailored risk‐guided surveillance strategies could improve resource allocation and clinical outcomes in managing Barrett's esophagus. The conserved resources can then be utilized to identify high‐risk individuals in the community.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusCost-Benefit AnalysisCost-Effectiveness AnalysisEsophageal NeoplasmsEsophagoscopyPopulation SurveillanceHumansMarkov ChainsAdenocarcinomaMaleFemaleDisease ProgressionTime Factors

Stichwörter der Autor:innen

Barrett's esophagusMarkov modelcost‐utility analysisendoscopic surveillance

Autor:innen und Institutionen

  • Discipline of Surgery, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Department of Surgery, Flinders Medical Centre, Adelaide, Australia.

ORCID-Profile: Roger Yazbeck

Förderung

  • Hospital Research Foundation
  • APAGE/JGH Foundation Clinician-Scientist Training Fellowship
  • Cancer Council South Australia Beat Cancer Early Career Research Fellowship

Zitieren

APA

Vissapragada, R., Bulamu, N. B., Yazbeck, R., Aoki, T., Bright, T., Watson, D. I., & Karnon, J. (2026). Evaluating Cost‐Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus. Journal of Gastroenterology and Hepatology, 41(3), 992-1000. https://doi.org/10.1111/jgh.70238

Vancouver

Vissapragada R, Bulamu NB, Yazbeck R, Aoki T, Bright T, Watson DI, et al. Evaluating Cost‐Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus. Journal of Gastroenterology and Hepatology. 2026;41(3):992-1000. doi:10.1111/jgh.70238

BibTeX
@article{Vissapragada2026,
  author = {Vissapragada, Ravi and Bulamu, Norma B and Yazbeck, Roger and Aoki, Tomonori and Bright, Tim and Watson, David I and Karnon, Jonathan},
  title = {Evaluating Cost‐Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {3},
  pages = {992--1000},
  doi = {10.1111/jgh.70238}
}
Kostenlos starten →